A.P. Pharma News
Most Popular A.P. Pharma Story
A.P. Pharma nausea drug hit with FDA rejection
A.P. Pharma's shares went into a tailspin this morning after the FDA rejected the company's anti-nausea drug, a long-acting formulation of granisetron for chemo-induced vomiting. And the company was... Read more...
Latest Headlines
- March 19, 2010
- May 29, 2009
- November 5, 2008
- September 30, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
